Xeris Biopharma Holdings, Inc.XERSNASDAQ
LOADING
|||
Switch Symbol:
EV to Sales: Discounted Valuation
Trending higher, below historical average, slight contraction.
Left:
||||
Enterprise value to sales ratio
Latest
3.43
↓ 84% below average
Average (8y)
21.09
Historical baseline
Range
High:81.87
Low:-0.66
CAGR
-3.7%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 3.43 | +16.0% |
| 2023 | 2.96 | +27.3% |
| 2022 | 2.33 | -54.3% |
| 2021 | 5.09 | -59.9% |
| 2020 | 12.69 | -84.5% |
| 2019 | 81.87 | +5.7% |
| 2018 | 77.47 | +11753.8% |
| 2017 | -0.66 | -114.3% |
| 2016 | 4.64 | - |